IOVA logo

IOVA

Iovance Biotherapeutics Inc.

$2.23
$0.00(0.00%)
45
Overall
--
Value
45
Tech
--
Quality
Market Cap
$886.54M
Volume
7.04M
52W Range
$1.64 - $12.51
Target Price
$9.10
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
----------------$1.2M$164.1M
Total Revenue
----------------$1.2M$164.1M
COST OF GOODS SOLD
Cost of Revenue
$-3.8M--------------$10.8M$124.0M
GROSS PROFIT
Gross Profit
$3.8M--------------$-9.6M$40.1M
OPERATING EXPENSES
Operating Expenses
$-27.9M$-53.6M$-92.9M$128.3M$206.9M$261.9M$342.7M$398.9M$451.0M$435.4M
Research & Development
$15.5M$26.9M$71.6M$99.8M$166.0M$201.7M$259.0M$294.8M$344.1M$282.3M
Research Expense
$15.5M$26.9M$71.6M$99.8M$166.0M$201.7M$259.0M$294.8M$344.1M$282.3M
Selling, General & Administrative
$12.4M$26.7M$21.3M$28.4M$40.8M$60.2M$83.7M$104.1M$106.9M$153.0M
General & Administrative Expenses
$12.4M$26.7M$21.3M$28.4M$40.8M$60.2M$83.7M$104.1M$106.9M$153.0M
Salaries & Wages
$-8.5M$-18.9M$-12.0M$-20.0M$24.3M$40.9M$69.8M----$109.6M
Depreciation & Amortization
$-1.0M$-1.0M$-1.0M$-1.0M$1.2M$1.1M$3.1M$9.3M$11.6M$12.0M
Depreciation & Amortization
$-1.0M$-1.0M$-1.0M$-1.0M$1.2M$1.1M$3.1M----$12.0M
Amortization
----------------$9.8M$21.3M
Other Operating Expenses
----$-1.3M$-2.1M$-3.7M$-4.4M$-3.9M----$-3.7M
OPERATING INCOME
Operating income
$-27.9M$-53.6M$-92.9M$-128.3M$-206.9M$-261.9M$-342.7M$-398.9M$-460.6M$-395.3M
EBITDA
$-26.7M$-52.0M$-91.1M$-124.0M$-199.8M$-253.2M$-328.7M$-374.8M$-414.4M$-331.3M
NON-OPERATING ITEMS
Intinc
$200.0K$745.0K$813.0K$4.7M$9.3M$2.4M$451.0K$3.0M$13.0M$20.3M
Net Non-Operating Interest Income/Expense
$200.0K$745.0K$813.0K$4.7M$9.3M$2.4M$451.0K$3.0M$13.0M$20.3M
Gain on Sale of Securities
--$32.0K----------------
Other Income/Expense
--$-32.0K----$-12.3M--------$1.8M
Other Special Charges
--------$12.3M----------
SPECIAL ITEMS
Other Impairment Of Capital Assets
------------------$7.4M
PRE-TAX INCOME
EBIT
$-27.7M$-52.9M$-92.1M$-123.6M$-197.6M$-261.9M$-342.7M$-395.9M$-447.5M$-375.0M
Pre-Tax Income
$-27.7M$-52.9M$-92.1M$-123.6M$-197.6M$-259.6M$-342.3M$-395.9M$-447.5M$-375.0M
INCOME TAX
Tax Provision
----$-1.3M$-223.0K$-47.0M$-59.9M----$-3.5M$-2.8M
NET INCOME
Net Income
$-27.7M$-52.9M$-92.1M$-123.6M$-197.6M$-259.6M$-342.3M$-395.9M$-444.0M$-372.2M
Net Income (Continuing Operations)
$-27.7M$-52.9M$-92.1M$-123.6M$-197.6M$-259.6M$-342.3M$-395.9M$-444.0M$-372.2M
Net Income (Discontinued Operations)
$-27.7M$-52.9M$-92.1M$-123.6M$-197.6M$-259.6M$-342.3M$-395.9M$-444.0M$-372.2M
Net Income (Common Stockholders)
$-27.7M$-102.3M$-92.1M$-123.6M$-197.6M$-259.6M$-342.3M$-395.9M$-444.0M$-372.2M
Normalized Income
------------------$-376.0M
TOTALS
Total Expenses
$27.9M$-53.6M$-92.9M$128.3M$206.9M$261.9M$342.7M$398.9M$461.7M$559.3M
SHARE & EPS DATA
Average Shares Outstanding
$44.4K$55.3K$65.2K$97.3K$124.3K$138.3K$153.4K$159.3K$235.1K$289.9K
Average Shares Outstanding (Diluted)
$44.6M$28.6M$65.3M$97.3K$124.3K$138.3K$153.4K$159.3K$235.1K$289.9K
Shares Outstanding
$48.6M$62.3M$89.4M$123.4M$126.5M$147.0M$157.2M$224.2M$279.3M$327.9M
Basic EPS
--------$-1.59$-1.88$-2.23$-2.49$-1.89$-1.28
Basic EPS (Continuing Operations)
--------$-1.59$-1.88$-2.23$-2.49$-1.89$-1.28
Diluted EPS
$-0.62$-1.85$-1.41$-1.27$-1.59$-1.88$-2.23$-2.49$-1.89$-1.28
Diluted EPS (Continuing Operations)
------$-1.27----$-2.23$-2.49$-1.89$-1.28
OTHER METRICS
Accrued Preferred Stock Dividends
--$49.5M----------------
Gain On Sale Of P P E
------------------$5.6M
Net Operating Interest Income Expense
$200.0K------------------
Other Gand A
$12.4M$26.7M$21.3M$28.4M$40.8M$60.2M$83.7M$104.1M$106.9M$153.0M
Otherunder Preferred Stock Dividend
--$49.5M----------------
Preferred Stock Dividends
--$49.5M----------------
Rent And Landing Fees
$12.4M$26.7M$21.3M$-1.0M------------

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2IOVA$2.230%7.04M
3
4
5
6

Get Iovance Biotherapeutics Inc. Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.